Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,218 | -80,893 | -58,179 | -40,146 | -18,728 |
| Depreciation Amortization | 536 | 1,069 | 580 | 318 | 106 |
| Accounts receivable | -21,500 | N/A | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | -376 | -544 | -539 | 1,318 | 262 |
| Other Working Capital | -3,539 | -2,540 | -6,036 | -4,537 | -4,591 |
| Other Operating Activity | 23,567 | 7,133 | 5,531 | 1,940 | 1,257 |
| Operating Cash Flow | $-19,530 | $-75,775 | $-58,643 | $-41,107 | $-21,694 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,750 | -3,324 | -32,944 | -39,294 | 16,142 |
| PPE Investments | -450 | -4,280 | -3,280 | -2,714 | -1,389 |
| Investing Cash Flow | $9,300 | $-7,604 | $-36,224 | $-42,008 | $14,753 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -20 | -14 | -8 | -7 |
| Common Stock Issued | 367 | 154,532 | 129,847 | 129,583 | 289 |
| Financing Cash Flow | $362 | $154,512 | $129,833 | $129,575 | $282 |
| Exchange Rate Effect | 7 | 51 | 4 | 0 | 0 |
| Beginning Cash Position | 91,937 | 20,753 | 20,753 | 20,753 | 20,753 |
| End Cash Position | 82,076 | 91,937 | 55,723 | 67,213 | 14,094 |
| Net Cash Flow | $-9,861 | $71,184 | $34,970 | $46,460 | $-6,659 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,530 | -75,775 | -58,643 | -41,107 | -21,694 |
| Capital Expenditure | -450 | -4,280 | -3,280 | -2,714 | -1,389 |
| Free Cash Flow | -19,980 | -80,055 | -61,923 | -43,821 | -23,083 |